Rubéole


Date de publication: 2021 Catégorie: Health care providers Type: Lien externe Canadian Immunization Guide: Evergreen Edition

Canadian Immunization Guide: Evergreen Edition

Evergreen edition presents information on the immunizing agents available in Canada and their use in the prevention of communicable diseases.

Auteurs collectifs: National Advisory Committee on Immunization
Éditeur: Public Health Agency of Canada

Date de publication: 2021 Catégorie: Type: Lien externe Guide canadien d'immunisation : Edition évolutive

Guide canadien d'immunisation : Edition évolutive

Le présent Guide (édition évolutive) contient des renseignements sur les agents immunisants disponibles au Canada et sur leur utilisation en vue de prévenir les maladies transmissibles.

Auteurs collectifs: Comité consultatif national de l'immunisation
Éditeur: Agence de la santé publique du Canada

Date de publication: 2021 Catégorie: Health care providers Type: Lien externe Use of Measles-Mumps-Rubella (MMR) Vaccine for the Management of Mumps Outbreaks in Canada: An Advisory Committee Statement

Use of Measles-Mumps-Rubella (MMR) Vaccine for the Management of Mumps Outbreaks in Canada: An Advisory Committee Statement

Auteurs collectifs: National Advisory Committee on Immunization
Éditeur: Public Health Agency of Canada

Date de publication: 2021 Catégorie: Type: Lien externe Utilisation du vaccin contre la rougeole, la rubéole et les oreillons (RRO) pour la prise en charge des éclosions d’oreillons au Canada : Déclaration d'un comité consultatif

Utilisation du vaccin contre la rougeole, la rubéole et les oreillons (RRO) pour la prise en charge des éclosions d’oreillons au Canada : Déclaration d'un comité consultatif

Auteurs collectifs: Comité consultatif national de l'immunisation
Éditeur: Agence de la santé publique du Canada

Date de publication: 2019 Catégorie: Parents Type: Lien externe MMR vaccine does not cause autism. Examine the evidence.

MMR vaccine does not cause autism. Examine the evidence.

There is no scientific evidence that MMR vaccine causes autism. The question about a possible link between MMR vaccine and autism has been extensively reviewed by independent groups of experts in the United States, including the National Academy of Sciences’ Institute of Medicine (now renamed the National Academy of Medicine). These reviews have concluded that the available epidemiologic evidence does not support a causal link between MMR vaccine and autism

Auteurs collectifs: Immunization Action Coalition
Éditeur: Immunization Action Coalition

Date de publication: 2018 Catégorie: Health care providers Type: Lien externe Strengthening routine immunization through measles-rubella elimination

Strengthening routine immunization through measles-rubella elimination

The 2016 mid-term review of the Global Measles-Rubella Strategic Plan 2012–20 for achieving measles-rubella elimination concluded that the full potential of strategies and activities to strengthen routine immunization (RI) service delivery had not been met. In December 2017, researchers contacted the World Health Organization (WHO) and partner agency immunization staff in all six WHO Regions who identified 23 countries working on measles or rubella elimination that have implemented examples of recommended activities to improve RI, adapted to their needs.

Auteurs: Biellik RJ and Orenstein WA
Numéro de la revue: 37
Titre de la revue: Vaccine
Volume de la revue: 36
Éditeur: Elsevier

Date de publication: 2017 Catégorie: Health care providers Type: Lien externe Parents of young children are more ‘vaccine hesitant’

Parents of young children are more ‘vaccine hesitant’

A solid majority of Americans believe vaccinating their children against measles, mumps and rubella has high preventive health benefits. But several groups – particularly parents of young children – are less convinced of the benefits and more concerned about the safety of the MMR vaccine.

Auteurs collectifs: Pew Research Center
Éditeur: Pew Research Center

Date de publication: 2017 Catégorie: Health care providers Type: Lien externe Progress in Rubella and Congenital Rubella Syndrome Control and Elimination — Worldwide, 2000–2016

Progress in Rubella and Congenital Rubella Syndrome Control and Elimination — Worldwide, 2000–2016

During 2000-2016, rubella-containing vaccine was introduced in 53 countries, including 20 introductions after 2012. By December 2016, 152 (78%) of 194 countries were using the vaccine. These introductions and increased rubella vaccine coverage globally resulted in a decrease in reported rubella cases from 670,894 cases in 2000, to 94,277 cases in 2012, to 22,361 cases in 2016. Elimination of rubella and congenital rubella syndrome was verified in the WHO Region of the Americas in 2015, and 33 (62%) of 53 countries in the European Region have now eliminated endemic rubella and congenital rubella syndrome.

Auteurs: Grant G et al.
Numéro de la revue: 45
Titre de la revue: Morbidity and Mortality Weekly Report
Volume de la revue: 66
Éditeur: US Department of Health and Human Services/Centers for Disease Control and Prevention

Date de publication: 2017 Catégorie: Health care providers Type: Lien externe Seroprevalence of rubella antibodies and determinants of susceptibility to rubella in a cohort of pregnant women in Canada, 2008–2011

Seroprevalence of rubella antibodies and determinants of susceptibility to rubella in a cohort of pregnant women in Canada, 2008–2011

This study was undertaken to estimate rubella susceptibility in a cohort of pregnant women in Canada and to identify associated socioeconomic and demographic factors.

Auteurs: Gilbert N et al.
Numéro de la revue: April 29, 2017
Titre de la revue: Vaccine
Éditeur: Elsevier

Date de publication: 2017 Catégorie: Parents, Adults Type: Lien externe What would happen if we stopped vaccinations?

What would happen if we stopped vaccinations?

Emphasizes that while vaccination programs have eliminated or significantly reduced many vaccine-preventable diseases, these diseases still exist and can once again become common and deadly if vaccination coverage does not continue at high levels.

Auteurs collectifs: Centers for Disease Control and Prevention
Éditeur: Centers for Disease Control and Prevention